Results 181 to 190 of about 182,114 (282)
Botulinum toxin type A injection in treatment of pediatric cyclic esotropia. [PDF]
Front Med (Lausanne)Huang Y, Fu T, Zhang X, Li X, Wang C.
europepmc +1 more source
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1500-1506, November 2026.ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang +2 more
wiley +1 more source
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1545-1555, November 2026.ABSTRACT Objective To synthesize the evidence on the efficacy and safety of mirabegron and intradetrusor onabotulinumtoxinA (BoNT‐A) as separate interventions for overactive bladder (OAB) in Parkinson's disease (PD). Methods A systematic review and meta‐analysis with parallel synthesis of two distinct interventions was conducted of randomized and ...
Hussain Arshad +4 more
wiley +1 more source
Advancing Personalized Care for Neurogenic Bladder: The Case for Continent Urinary Diversion
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1489-1492, November 2026.ABSTRACT Introduction Neurogenic lower urinary tract dysfunction (NLUTD) with a poorly compliant bladder that is refractory to minimally invasive therapies (MIT) represents an “end‐stage” phenotype in which the principal objectives are durable upper urinary tract protection and restoration of continence with acceptable long‐term morbidity.
Francis A. Jefferson, Maude E. Carmel
wiley +1 more source
Botulinum Toxin Type A for Cervicogenic Headache: A Review of the Current Evidence. [PDF]
CureusVasconcelos Fonseca C +1 more
europepmc +1 more source
Urodynamic Voiding Patterns in Multiple Sclerosis
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1569-1577, November 2026.ABSTRACT Aims This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies.
Camille Chesnel +5 more
wiley +1 more source
Randomized, double-blind pilot study on botulinum toxin type A in the treatment of axillary hidradenitis suppurativa. [PDF]
An Bras DermatolKim JSTW +6 more
europepmc +1 more source
Recombinant versus native botulinum neurotoxin type A: structural and pharmacodynamic comparison
Acta Crystallographica Section F, Volume 82, Issue 11, Page 391-401, November 2026.For the first time, the recombinant core botulinum neurotoxin type A (BoNT/A) expressed in Escherichia coli and nicked in vitro is shown to be structurally identical to native BoNT/A from Clostridium botulinum, enabling direct activity comparison between the recombinant product and the native toxin.Botulinum neurotoxins (BoNTs) are highly potent ...
Zongren Yao +9 more
wiley +1 more source
Botulinum Toxin for Temporomandibular Disorder: Current Evidence, Clinical Applications, and Future Perspectives. [PDF]
Toxins (Basel)Ferrillo M +9 more
europepmc +1 more source
BJU International, Volume 138, Issue 5, Page 750-758, November 2026.Objective To examine the role of health‐related quality of life (HRQoL) assessments and patient‐reported outcome measures (PROMs) in the economic evaluation of urological interventions, highlighting methodological challenges, and identifying areas for future development.
Mohammed El Bahnasawi +4 more
wiley +1 more source